FIELD: medicine.
SUBSTANCE: in patients with IHD before therapy with acetylsalisylic acid (ASA) ADP-induced and ASA-dependent platelet aggregation are examined and by their difference value of coefficient of aggregation inhibition (CAI) is calculated. CAI value <24% testifies to resistance to ASA, if CAI ≥24% - about sensitivity to ASA.
EFFECT: method ensures high prediction accuracy and makes it possible to prevent development of undesirable coronary events in IHD patients.
1 tbl, 4 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING THROMBOCYTE SENSITIVITY TO ACETYLSALICYLIC ACID | 2018 |
|
RU2699569C1 |
| METHOD FOR RAPID DIAGNOSIS OF RESISTANCE AND SUSCEPTIBILITY TO ACETYLSALICYLIC ACID | 2015 |
|
RU2578428C1 |
| METHOD FOR DIAGNOSTICS OF ASPIRIN RESISTANCE IN PATIENTS WITH CORONARY HEART DISEASE | 2007 |
|
RU2348041C1 |
| METHOD OF INDIVIDUAL PROGNOSIS OF CLINICAL EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2639772C1 |
| METHOD FOR PREDICTION OF ANTIPLATELET THERAPY EFFICIENCY REDUCTION RISK | 2016 |
|
RU2623051C1 |
| METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE FOLLOWING CORONARY ARTERY BYPASS SURGERY | 2011 |
|
RU2466395C1 |
| METHOD OF DETERMINING ANTI-THROMBOTIC EFFECT OF ACETYLSALICYLIC ACID | 2007 |
|
RU2379684C2 |
| METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ANTIAGGREGANT THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2011 |
|
RU2486523C1 |
| METHOD OF DETERMINING THROMBOCYTE RESISTANCE TO DOUBLE ANTIPLATELET THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2019 |
|
RU2710272C1 |
| METHOD OF DETERMINING PLATELET RESISTANCE TO ACETYLSALICYLIC ACID | 2013 |
|
RU2538219C2 |
